19-11030830-C-T
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS1
The NM_001387283.1(SMARCA4):c.3483C>T(p.Leu1161Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000255 in 1,608,242 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L1161L) has been classified as Likely benign.
Frequency
Consequence
NM_001387283.1 synonymous
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -17 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.3483C>T | p.Leu1161Leu | synonymous_variant | Exon 25 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
| SMARCA4 | ENST00000344626.10 | c.3483C>T | p.Leu1161Leu | synonymous_variant | Exon 25 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
| SMARCA4 | ENST00000643549.1 | c.3483C>T | p.Leu1161Leu | synonymous_variant | Exon 25 of 35 | ENSP00000493975.1 | ||||
| SMARCA4 | ENST00000541122.6 | c.3483C>T | p.Leu1161Leu | synonymous_variant | Exon 26 of 35 | 5 | ENSP00000445036.2 | |||
| SMARCA4 | ENST00000643296.1 | c.3483C>T | p.Leu1161Leu | synonymous_variant | Exon 25 of 34 | ENSP00000496635.1 | ||||
| SMARCA4 | ENST00000644737.1 | c.3483C>T | p.Leu1161Leu | synonymous_variant | Exon 25 of 34 | ENSP00000495548.1 | ||||
| SMARCA4 | ENST00000589677.5 | c.3483C>T | p.Leu1161Leu | synonymous_variant | Exon 26 of 35 | 5 | ENSP00000464778.1 | |||
| SMARCA4 | ENST00000643995.1 | c.2895C>T | p.Leu965Leu | synonymous_variant | Exon 22 of 32 | ENSP00000496004.1 | ||||
| SMARCA4 | ENST00000644963.1 | c.2127C>T | p.Leu709Leu | synonymous_variant | Exon 18 of 28 | ENSP00000495599.1 | ||||
| SMARCA4 | ENST00000644065.1 | c.2208C>T | p.Leu736Leu | synonymous_variant | Exon 18 of 27 | ENSP00000493615.1 | ||||
| SMARCA4 | ENST00000642350.1 | c.1968C>T | p.Leu656Leu | synonymous_variant | Exon 17 of 27 | ENSP00000495355.1 | ||||
| SMARCA4 | ENST00000643857.1 | c.1836C>T | p.Leu612Leu | synonymous_variant | Exon 16 of 25 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152194Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000632 AC: 15AN: 237450 AF XY: 0.0000465 show subpopulations
GnomAD4 exome AF: 0.0000220 AC: 32AN: 1455930Hom.: 0 Cov.: 31 AF XY: 0.0000207 AC XY: 15AN XY: 723692 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152312Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74474 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Benign:2
- -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Rhabdoid tumor predisposition syndrome 2 Benign:1
- -
SMARCA4-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at